3 9 4 6 8
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.799 Clin Epidemiol
- 3.702 Cancer Manag Res
- 3.443 Infect Drug Resist
- 2.505 Clin Interv Aging
- 2.935 Drug Des Dev Ther
- 2.917 Int J Chronic Obstr
- 4.370 Int J Nanomed
- 2.195 Neuropsych Dis Treat
- 2.656 OncoTargets Ther
- 1.733 Patient Prefer Adher
- 1.995 Ther Clin Risk Manag
- 2.645 J Pain Res
- 2.961 Diabet Metab Synd Ob
- 1.952 Psychol Res Behav Ma
-
Original Research
对晚期软组织肉瘤患者使用帕唑帕尼、索拉非尼和舒尼替尼所产生的与治疗相关的不良反应：一项汇总分析
- 作者：Yi Que, Yao Liang, Jingjing Zhao, Ya Ding, Ruiqing Peng, Yuanxiang Guan, Xing Zhang
- 期刊：Cancer Management and Research
-
Original Research
术前循环 FPR 和 CCF 评分是预测 II-III 期结直肠癌患者临床结果的有前途的生物标志物
- 作者：Fan Sun, Hong-Xin Peng, Qiu-Fang Gao, Shu-Qi Li, Jing Zhang, Qing-Gen Chen, Yu-Huan Jiang, Lei Zhang, Xiao-Zhong Wang, Hou-Qun Ying
- 期刊：Cancer Management and Research
-
Original Research
Beclin-1 在非小细胞肺癌中的预后和临床病理意义：一项综合分析
- 作者：Tianliang Zheng, Deping Li, Zhanfeng He, Shuaibing Feng, Song Zhao
- 期刊：OncoTargets and Therapy
-
Review
阿帕替尼治疗实体瘤的进展：一个系统的回顾
- 作者：Deze Zhao, Helei Hou, Xiaochun Zhang
- 期刊：OncoTargets and Therapy
-
Original Research
阻止 MUC1-C 进入核中可遏制 MYC 表达并减轻食管鳞状细胞癌的恶性生长
- 作者：Zhongwei Xin, Gongsun Xin, Mo Shi, Liang Song, Qiang Wang, Bin Jiang, Xiangyan Liu
- 期刊：OncoTargets and Therapy
-
Original Research
DcR3 通过 PI3K/AKT/GSK-3β/β-连环蛋白信号通路在胃癌细胞中诱导增殖、迁移、侵袭和 EMT
- 作者：Hua Ge, Chaojie Liang, Zhixia Li, Dali An, Shulin Ren, Chaosen Yue, Jixiang Wu
- 期刊：OncoTargets and Therapy